This page provides Regulatory news filings submitted by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.

 

Hamilton, Bermuda: August 3, 2021 - The Bermuda Stock Exchange announces the admission of the following securities to its Official List:

 

 

 

·         Name of Issuer: - Jazz Pharmaceuticals UK Holdings Limited

 

 

 

• Description of Securities: - 4.6% Fixed Rate Note due 15 January 2029.

 

 

 

·         Nominal Amount of Securities: - US$2,960,000,000 of Notes.

 

 

 

·         Listing Classification: - Section IIIB – International Issuers Debt Securities.

 

 

 

·         Method of Listing: - Introduction

 

 

 

·         Date of Admission to Listing: - August 3, 2021

 

 

 

·         Listing Sponsor: - First Bermuda Securities Limited.

 

 

 

                                                # # #

 

 

 

For more information on the Bermuda Stock Exchange (BSX), contact Nancy Vieira at 1-441-292-7212 or nvieira@bsx.com. Information is also available at www.bsx.com and on Bloomberg at BSX <GO> the BSX was founded in 1971 and is the world’s leading fully electronic offshore securities market. The BSX list equities, mutual funds and bonds, depository receipts and derivative warrant securities. The BSX is a full member of the World Federation of Exchanges (WFE) and an affiliate member of IOSCO. In addition, the BSX is recognized by the U.S. Securities & Exchange Commission (SEC) as a Designated Offshore Securities Market under Regulation S; The Financial Services Authority in the UK as a Designated Investment Exchange; HM Revenue & Customs in the UK as a Recognized Stock Exchange; The Bermuda Monetary Authority as a Recognised Investment Exchange and as an Approved Stock Exchange under Australia’s Foreign Investment Funds (FIF) taxation rules.